2017
DOI: 10.1016/j.ejps.2017.07.034
|View full text |Cite
|
Sign up to set email alerts
|

Cytochrome P450 inhibition by three licorice species and fourteen licorice constituents

Abstract: The potential of licorice dietary supplements to interact with drug metabolism was evaluated by testing extracts of three botanically identified licorice species (Glycyrrhiza glabra L., Glycyrrhiza uralensis Fish. ex DC. and Glycyrrhiza inflata Batalin) and 14 isolated licorice compounds for inhibition of 9 cytochrome P450 enzymes using a UHPLC-MS/MS cocktail assay. G. glabra showed moderate inhibitory effects against CYP2B6, CYP2C8, CYP2C9, and CYP2C19, and weak inhibition against CYP3A4 (testosterone). In co… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

1
38
0

Year Published

2018
2018
2023
2023

Publication Types

Select...
6
2
1

Relationship

0
9

Authors

Journals

citations
Cited by 57 publications
(39 citation statements)
references
References 40 publications
1
38
0
Order By: Relevance
“…55 It should be noted that some previous investigations have revealed that licorice constituents can affect the pharmacokinetic behaviour of some therapeutic drugs via inhibiting the hepatic drug metabolizing enzymes (cytochrome P450 enzymes and UDP-glucuronosyltransferases). [56][57][58] In this study, our results demonstrate that thrombin activity can be inhibited by the chalcones in licorice. Therefore, it is conceivable that both pharmacokinetic and pharmacodynamics interactions may occur when anticoagulant or antiplatelet drugs are used in combination with licorice-containing products.…”
Section: Discussionsupporting
confidence: 57%
“…55 It should be noted that some previous investigations have revealed that licorice constituents can affect the pharmacokinetic behaviour of some therapeutic drugs via inhibiting the hepatic drug metabolizing enzymes (cytochrome P450 enzymes and UDP-glucuronosyltransferases). [56][57][58] In this study, our results demonstrate that thrombin activity can be inhibited by the chalcones in licorice. Therefore, it is conceivable that both pharmacokinetic and pharmacodynamics interactions may occur when anticoagulant or antiplatelet drugs are used in combination with licorice-containing products.…”
Section: Discussionsupporting
confidence: 57%
“…Induction of aromatase and thus increase of breast cancer risk can be associated with ethanol. Liquorice (glycyrrhizin from glycyrrhiza glabra) reduces serum testosterone and induces ovulation by induction of aromatase (85)(86)(87)(88)(89)(90). Various flavonoids have been tested and the effect been quantified on cell lines only, but not in vivo (e.g., H295R adrenocortical carcinoma cells).…”
Section: Flavonoids As Inhibitors Of Estradiol's Actionmentioning
confidence: 99%
“…Important examples of agents influencing CYP3A4 are displayed in (▶ table 4S). Curiously, diverse natural compounds, such as for instance grapefruit, pomegranate, ginkgo, echinacea, St. John's wort, or licorice, impair the cytochrome's function as well [49][50][51][52][53][54][55][56][57].…”
Section: Drug Interactionsmentioning
confidence: 99%